Resistensen hos antiretroviralt behandlingserfarne patienter forekommer hovedsageligt ved akkumulering af de primære og sekundære resistenssubstitutioner beskrevet tidligere som værende involverede i proteasehæmmerresistens.
The resistance in antiretroviral treatment experienced patients mainly occurs by accumulation of the primary and secondary resistance substitutions described previously to be involved in protease inhibitor resistance.